Tandem Suspension Notice Update
14th December 2020
Recently the Therapeutic Goods Administration (TGA) expressed concern about the Tandem Diabetes Care t:slim X2 insulin pump.
The TGA have recently issued a statement on their website which provides more information on this situation, found here.
We would like to reassure everyone that we are continuing to work alongside the TGA to alleviate their concerns and have the existing Tandem t:slim X2 insulin pump suspension lifted as quickly as possible.
For more information we encourage you to email our Customer Care Team at diabetes@amsl.com.au to keep our phone lines available for urgent technical support. Alternatively, please call 1300 851 056.
Tandem Suspension Notice Update
Other News
Important Dexcom Update
Important Dexcom G4 PLATINUM & Dexcom G5 Mobile Update
On the 2nd April 2020, Dexcom announced the upcoming obsolescence for Dexcom
Important Update:
Important Message from AMSL General Manager, Ian Slater on COVID-19
23rd March 2020
The impact of COVID-19 has been unprecedented as it continues to
Dexcom G6 CGM System Update
Sydney, Australia, March 2020
The Dexcom G6 Continuous Glucose Monitoring (CGM) System, has been registered in Australia (ARTG 330535).
The Australian Government Simplifies the Clinical Eligibility
Sydney, Australia, March 2020
The Australian Government is simplifying the clinical eligibility criteria for the Continuous Glucose Monitoring (CGM) Initiative